D. Weisdorf

发表

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

J. Dipersio, J. Liesveld, S. Devine, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

L. Lanier, Jeffrey S. Miller, D. Weisdorf, 2012, Blood.

Emerging Therapies for Chronic GVHD

J. Vose, J. Wingard, A. Keating, 2002 .

Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.

J. Steinberger, K. Ness, C. Sklar, 2005, Blood.

Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft‐versus‐host disease: analysis of BMT CTN‐0201 and ‐0901 samples

D. Weisdorf, B. Blazar, A. Rashidi, 2018, British journal of haematology.

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.

T. Fleming, E. Anaissie, R. Beveridge, 2004, Leukemia research.

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic natural killer cells for refractory lymphoma

B. Lindgren, Jeffrey S. Miller, D. Weisdorf, 2010, Cancer Immunology, Immunotherapy.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

James Ferrara, Peter A Lachenbruch, Daniel Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Core‐binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy

D. Weisdorf, S. Yohe, M. Solh, 2014, American journal of hematology.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

L. Weiner, Jeffrey S. Miller, J. Ross, 2014, Blood.

MYELOID NEOPLASIA CD 16 xCD 33 bispeci fi c killer cell engager ( BiKE ) activates NK cells against primary MDS and MDSC CD 33 1 targets

L. Weiner, Jeffrey S. Miller, J. Ross, 2014 .

Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations.

R. Branda, D. Arthur, P. Flynn, 1983, Blood.

Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II–IV acute GvHD: a systematic review and meta-analysis

D. Weisdorf, A. Rashidi, 2017, Bone Marrow Transplantation.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Kyle M. Hebert, M. Pasquini, M. Horowitz, 2020, Biology of Blood and Marrow Transplantation.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

J. Wagner, K. Dusenbery, M. MacMillan, 2015, Blood.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.

D. Weisdorf, C. Ustun, Jo-Anne H. Young, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Radiation Injury Treatment Network (RITN): Healthcare professionals preparing for a mass casualty radiological or nuclear incident

R. Hatchett, D. Weinstock, R. Hartzman, 2011, International journal of radiation biology.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, A. Blaes, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late mortality in blood or marrow transplant survivors with venous thromboembolism: report from the Blood or Marrow Transplant Survivor Study

S. Bhatia, D. Weisdorf, M. Arora, 2019, British journal of haematology.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Peter Parham, Tracy L. Bergemann, Chap T. Le, 2009, Blood.

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

P. Parham, K. van Besien, S. Farag, 2020, Blood advances.

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.

P. Parham, Jeffrey S. Miller, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR Donor Selection: Feasibility in Identifying better Donors.

P. Parham, S. Marsh, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

J. Dipersio, D. Porter, S. Farag, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype.

J. Klein, Jeffrey S. Miller, S. Spellman, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, 2010, Best practice & research. Clinical haematology.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.

M. Mohty, Shaji K. Kumar, M. Pasquini, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2005, Blood.

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

J. Klein, P. Parham, M. Horowitz, 2007, Blood.

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

J. Wagner, C. Verfaillie, S. Davies, 1995, Blood.

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning.

J. Wagner, M. Kirstein, D. Weisdorf, 2016, Translational research : the journal of laboratory and clinical medicine.

Parainfluenza virus respiratory infection after bone marrow transplantation.

H. Balfour, D. Weisdorf, C. Wendt, 1992, The New England journal of medicine.

Ibuprofen inhibits granulocyte responses to inflammatory mediators

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

Influence of dietary omega-3 fatty acids on granulocyte function

D. Weisdorf, C. Lammi-Keefe, H. Jacob, 1982, Inflammation.

Chronic Myelogenous Leukemia: Development of Blast Crisis With Both Lymphoid and Myeloid Features

T. Lebien, P. Flynn, D. Weisdorf, 1983 .

Acute graft-versus-host disease: a bench-to-bedside update.

M. Pasquini, D. Weisdorf, S. Holtan, 2014, Blood.

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006, Blood.

Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injury.

D. Weisdorf, H. Jacob, D. Hammerschmidt, 1981, The Journal of laboratory and clinical medicine.

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

M. Horowitz, J. Pidala, Stephanie J. Lee, 2016, Haematologica.

Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.

D. Weisdorf, B. Oran, Q. Cao, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21).

C. Bloomfield, H. Deeg, K. Mrózek, 2021, Blood advances.

Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)

C. Bloomfield, E. Moodie, K. Mrózek, 2018, Cancer medicine.

First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia.

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2019, Blood advances.

Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.

J. Wagner, D. Arthur, S. Davies, 1996, Bone marrow transplantation.

Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia.

D. Weisdorf, S. Forman, 2009, Cancer treatment and research.

The Future of Transplantation: Hope, Investigative Discipline, and Fairness

D. Weisdorf, 2020, Contemporary Bone Marrow Transplantation.

Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies

H. Kantarjian, Jeffrey S. Miller, A. Frankel, 2015, Clinical Cancer Research.

Phase I Study of a Bispeci fi c Ligand-Directed Toxin Targeting CD 22 and CD 19 ( DT 2219 ) for Refractory B-cell Malignancies

H. Kantarjian, Jeffrey S. Miller, A. Frankel, 2015 .

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

C. Le, J. Wagner, Jeffrey S. Miller, 2005, Blood.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

J. Sierra, J. Dipersio, B. George, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

J. Klein, A. Barrett, M. Horowitz, 1998, Bone Marrow Transplantation.

Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation.

R. Chityala, R. Corvò, K. Tournel, 2015, International journal of radiation oncology, biology, physics.

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

D. Munn, Jeffrey S. Miller, D. Weisdorf, 2011, Blood.

Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.

D. Weisdorf, E. Gluckman, V. Rocha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

John P Klein, Daniel J Weisdorf, J. Klein, 2002, Blood.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

H. Greinix, Stephanie J. Lee, M. Flowers, 2015 .

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

disease: a multicenter study Performance of a new clinical grading system for chronic graft-versus-host

J. Lynch, M. Horowitz, Stephanie J. Lee, 2013 .

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Blood.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

GVHD the nuts and bolts.

D. Weisdorf, 2007, Hematology. American Society of Hematology. Education Program.

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.

J. Lynch, S. Piantadosi, M. Horowitz, 2003, Blood.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

J. V. Stone, J. Klein, J. Wingard, 1999, The New England journal of medicine.

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

C. Verfaillie, S. Davies, D. Weisdorf, 1996, Blood.

Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.

D. Weisdorf, B. Blazar, J. Kersey, 1994, Bone marrow transplantation.

Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.

Christopher G. Kanakry, B. Sandmaier, C. Hourigan, 2021, Transplantation and cellular therapy.

The role of second transplants for leukemia.

D. Weisdorf, 2016, Best practice & research. Clinical haematology.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

N. Kröger, D. Porter, C. June, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Bone Marrow Transplantation.

Oligodeoxynucleotide CpG 7909 Delivered as Intravenous Infusion Demonstrates Immunologic Modulation in Patients With Previously Treated Non-Hodgkin Lymphoma

A. Bossler, D. Weisdorf, G. Weiner, 2006, Journal of immunotherapy.

Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplant Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Typical and Atypical Mycobacterium Infections After Hematopoietic Stem Cell or Solid Organ Transplantation

D. Weisdorf, Jo-Anne H. Young, 2016 .

Housing Deadline for Tandem BMT Meetings

J. Vose, J. Wingard, R. Negrin, 2002 .

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.

Jeffrey S. Miller, S. Spellman, D. Weisdorf, 2018, Blood advances.

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

D. Weisdorf, M. Arora, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services.

M. Horowitz, D. Weisdorf, C. Cutler, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.

S. Duval, D. Weisdorf, Uma S. Valeti, 2017, Anticancer research.

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402

G. Vercellotti, M. MacMillan, Juan Wu, 2017, Bone Marrow Transplantation.

Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood

S. Bhatia, D. Weisdorf, M. Arora, 2018, JAMA oncology.

Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.

S. Bhatia, D. Weisdorf, M. Arora, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

J. Wagner, K. Ballen, R. Soiffer, 2017 .

Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.

D. Weisdorf, V. Bachanova, L. Burns, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality

M. Robin, M. Pasquini, Richard J. Jones, 2015 .

Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma

D. Weisdorf, V. Bachanova, J. Miller, 2009, Bone Marrow Transplantation.

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2018, Cancer Immunology, Immunotherapy.

haploidentical NK cells in cancer patients Successful adoptive transfer and in vivo expansion of human

Jeffrey S. Miller, D. Weisdorf, A. Panoskaltsis-Mortari, 2012 .

Surveillance imaging after autologous hematopoietic cell transplantation predicts survival in patients with diffuse large B cell lymphoma.

D. Weisdorf, V. Bachanova, Z. Cayci, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic

J. Vose, J. Radich, N. Kröger, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Health Behaviors and Cancer Screening Practices in Long-term Survivors of Hematopoietic Cell Transplantation (HCT): A Report from the Bone Marrow Transplant Survivor Study (BMTSS)

S. Bhatia, D. Weisdorf, S. Forman, 2010, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

C. Kollman, E. Petersdorf, D. Weisdorf, 2002, Blood.

Late-Onset Noninfectious Pulmonary Complications in Adult Allogeneic Hematopoietic Cell Transplant Recipients

D. Weisdorf, M. Solh, N. Majhail, 2011, Transplantation.

Proteome Profiling in Lung Injury after Hematopoietic Stem Cell Transplantation.

M. Steinbach, Vipin Kumar, Baolin Wu, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proteome Profiling in Lung Injury Following Hematopoietic Stem Cell Transplantation

Vipin, P. Bitterman, M. Bhargava, 2016 .

Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review

V. Roy, D. Weisdorf, V. Roy, 1997, Bone Marrow Transplantation.

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

L. Robison, T. Kawashima, W. Leisenring, 2010, Blood.

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee.

E. Thiel, J. Klein, M. Horowitz, 1995, Annals of internal medicine.

Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.

D. Snover, D. Weisdorf, B. Blazar, 1990, Blood.

Morphologic and quantitative changes in blood and marrow cells following growth factor therapy.

D. Weisdorf, R. Brunning, C. Litz, 1994, American journal of clinical pathology.

J. Wagner, K. Dusenbery, S. Davies, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

A. Ashrani, D. Weisdorf, N. Key, 2006, Bone Marrow Transplantation.

Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial.

C. Verfaillie, D. Weisdorf, B. Blazar, 1994, Blood.

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy.

J. Neglia, D. Arthur, Jeffrey S. Miller, 1994, Blood.

Diffuse alveolar hemorrhage: an evolving problem?

D. Weisdorf, 2003, Leukemia.

The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples.

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2019, Blood advances.

Late Effects in Survivors of Acute Leukemia Treated with Hematopoietic Cell Transplantation: a Report from the Bone Marrow Transplant Survivor Study

K. Ness, S. Bhatia, D. Weisdorf, 2010, Leukemia.

Management of the Bone Marrow Transplant Patient

D. Weisdorf, M. Tomblyn, 2006 .

Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2018, Bone Marrow Transplantation.

Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD

D. Weisdorf, B. Blazar, A. Rashidi, 2018, Bone Marrow Transplantation.

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.

Allen R. Chen, D. Weisdorf, D. Couriel, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

J. Bolaños-Meade, Juan Wu, S. Paczesny, 2012, Blood.

Lasting shift in the gut microbiota in patients with acute myeloid leukemia

A. Khoruts, C. Staley, D. Weisdorf, 2022, Blood advances.

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

D. Weisdorf, J. Miller, T. Repka, 2000, Experimental hematology.

Risk of Relapse (REL) after Umbilical Cord Blood Transplantation (UCBT) in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients

T. Pruett, S. Richmond, D. Weisdorf, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

HEMORRHAGIC CYSTITIS AFTER BONE MARROW TRANSPLANTATION RISK FACTORS AND COMPLICATIONS

S. Sencer, D. Weisdorf, R. Haake, 1993, Transplantation.

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.

M. Horowitz, K. Rai, R. Gale, 1999, Leukemia research.

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.

M. Horowitz, K. Rai, R. Gale, 1998, Leukemia research.

Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study

S. Bhatia, D. Weisdorf, M. Arora, 2020, Cancer.

Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.

D. Weisdorf, J. V. van Burik, P. Foy, 2007, Biology of Blood and Marrow Transplantation.

Neurological Consequences of Cytokine Release Syndrome Following Subcutaneous Recombinant IL-15 and Haploidentical Donor Natural Killer Cell Therapy for Advanced Acute Myeloid Leukemia

T. Waldmann, G. Vercellotti, Jeffrey S. Miller, 2017 .

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new standard in GVHD prophylaxis? An introduction to BMT CTN 1703.

W. Wood, Bryce Waldman, Z. DeFilipp, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM).

K. Owzar, C. Hofmeister, R. Vij, 2015 .

Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104

K. Owzar, C. Hofmeister, R. Vij, 2015 .

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2021, Blood advances.

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

D. Weisdorf, B. Blazar, J. Kersey, 1990, Blood.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

D. Weisdorf, N. Majhail, C. Brunstein, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

J. Weiss, Stephanie J. Lee, O. Schueller, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pulmonary symptoms measured by the NIH Lung score predict overall survival, non-relapse mortality and patient-reported outcomes in chronic GVHD

W. Wood, B. Kurland, J. Pidala, 2014 .

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

W. Wood, B. Kurland, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, 2008, Best practice & research. Clinical haematology.

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

J. Klein, M. Horowitz, Stephanie J. Lee, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Newsletter 1 High Resolution Donor HLA-Matching : Saving Lives

J. Lipton, O. Ringdén, D. Weisdorf, 2006 .

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants.

C. Hurley, D. Weisdorf, B. Logan, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocytes utilize different energy sources for movement and phagocytosis

D. Weisdorf, H. Jacob, P. Craddock, 1982, Inflammation.

Infections in Recipients of Hematopoietic Cell Transplantation

D. Weisdorf, Jo-Anne H. Young, 2010 .

Infections in recipients of blood and marrow transplantation.

D. Weisdorf, J. V. van Burik, J. V. Burik, 1999, Hematology/oncology clinics of North America.

Beta-adrenergic blockade: augmentation of neutrophil-mediated inflammation.

D. Weisdorf, H. Jacob, 1987, The Journal of laboratory and clinical medicine.

Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types

D. Weisdorf, A. Rashidi, C. Ryan, 2020, ESMO Open.

Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation

A. Khoruts, C. Staley, D. Weisdorf, 2019, Cancer.

Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia

A. Khoruts, C. Staley, D. Weisdorf, 2022, Scientific Data.

Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.

W. Woods, B. Bostrom, D. Weisdorf, 1989, Bone marrow transplantation.

Association between genetic variants in the base excision repair pathway and outcomes after hematopoietic cell transplantations.

B. Lindgren, M. Gross, S. Basu, 2010, Biology of Blood and Marrow Transplantation.

Polymorphisms in the Base Excision Repair Pathway and Graft-versus-Host Disease

B. Lindgren, M. Gross, S. Basu, 2010, Leukemia.

Association Between Genetic Variants in the Base Excision Repair Pathway and Outcomes After Hematopoietic Cell Transplant.

B. Lindgren, M. Gross, S. Basu, 2009 .

One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

N. Kröger, H. Baldomero, M. Aljurf, 2019, Blood.

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2014 .

Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature.

D. Weisdorf, T. Repka, P. Haddad, 2002, The American journal of medicine.

Blood transfusions and pulmonary complications after hematopoietic cell transplantation

D. Weisdorf, J. McCullough, M. Solh, 2016, Transfusion.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2020, Bone Marrow Transplantation.

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

R. Vij, M. Perales, F. Appelbaum, 2015, Blood.

Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report

P. Lachenbruch, D. Miklos, E. Holler, 2006 .

Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.

D. Weisdorf, H. Enright, R. Haake, 1990, The American journal of medicine.

Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.

J. Ledbetter, D. Weisdorf, J. Kersey, 1992, Blood.

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2016, Clinical Cancer Research.

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

GVHD prevention: an ounce is better than a pound.

D. Weisdorf, G. Socié, C. Cutler, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood Vs. Marrow Allogeneic Stem Cell Transplantation

D. Weisdorf, B. Mcclune, 2010 .

K. Dusenbery, D. Arthur, G. Vercellotti, 1996, Bone marrow transplantation.

Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.

D. Arthur, D. Weisdorf, R. Rydell, 1992, Leukemia.

Allogeneic hematopoietic cell transplantation in systemic mastocytosis: is there a high risk for veno‐occlusive disease?

P. Valent, S. Devine, D. Weisdorf, 2016, European journal of haematology.

Interleukin‐1 genotype and outcome of unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, D. Weisdorf, 2003, British journal of haematology.

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

E. Shpall, R. Soiffer, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

J. Wagner, D. Weisdorf, M. Verneris, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2009, Blood.

Analysis of failure times for multiple infections following bone marrow transplantation: an application of the multiple failure time proportional hazards model.

P. Hannan, D. Weisdorf, X. Shu, 1998, Statistics in medicine.

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2019, JCI insight.

Autologous bone marrow versus non‐mobilized peripheral blood stem cell transplantation for lymphoid malignancies: A prospective, comparative trial

C. Verfaillie, D. Weisdorf, B. Blazar, 1997 .

Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.

R. Corvò, G. Storme, K. Dusenbery, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.

B. Bostrom, D. Weisdorf, B. Peterson, 1990, Medical and pediatric oncology.

Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.

F. Uckun, D. Weisdorf, N. Ramsay, 1992, Blood.

Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis

D. Weisdorf, H. Jacob, P. Craddock, 1982 .

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation

D. Weisdorf, P. Jacobson, T. DeFor, 2007, Journal of clinical pharmacology.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

J. Sierra, J. Dipersio, S. Tarima, 2010, Blood.

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

J. Wagner, M. MacMillan, B. Hirsch, 2007, American journal of hematology.

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

J. Mehta, M. Tallman, G. Dewald, 2007, Blood.

Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia

P. Gupta, D. Weisdorf, B. Jahagirdar, 2008, American journal of hematology.

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

B. Sandmaier, M. Aljurf, M. Tallman, 2017, Cancer.

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: Myths, controversies, and unknowns (Blood (2011) 117, 8 (2307-2318))

M. Tallman, D. Weisdorf, Vikas Gupta, 2012 .

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

preparative regimen for advanced Hodgkin lymphoma donor hematopoietic stem cell transplantation after reduced-intensity Comparable results of umbilical cord blood and HLA-matched sibling

J. Wagner, D. Weisdorf, T. DeFor, 2013 .

Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.

J. Wagner, D. Weisdorf, T. DeFor, 2006, Blood.

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

M. Cazzola, H. Deeg, P. Greenberg, 2011 .

Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.

D. Arthur, G. Vercellotti, D. Weisdorf, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

S. Hirschfeld, Stephanie J. Lee, M. Flowers, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.

D. Snover, D. Weisdorf, S. Weisdorf, 1991, Transplantation.

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, O. Ringdén, 2017, American journal of hematology.

Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study

S. Bhatia, D. Weisdorf, M. Arora, 2020, Cancer.

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

K. Owzar, C. Hofmeister, R. Vij, 2010 .

Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).

D. Weisdorf, B. Blazar, J. Ferrara, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

T. Braun, D. Weisdorf, B. Blazar, 2006, Blood.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bin Zhang, Jeffrey S. Miller, D. Weisdorf, 2014, Blood.

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

C. Bloomfield, R. Larson, K. Mrózek, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

S. Zeger, G. Gui, C. Hourigan, 2022, medRxiv.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, V. Bachanova, 2008, Bone Marrow Transplantation.

Prognostic factors for clinical outcomes of patients with central nervous system leukemia

D. Weisdorf, V. Bachanova, N. Bejanyan, 2020, Hematology/oncology and stem cell therapy.

Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia

D. Weisdorf, A. Rashidi, M. Ebadi, 2019, British journal of haematology.

OUTCOMES OF UCB TRANSPLANTATION ARE COMPARABLE IN FLT3+ AML: RESULTS OF CIBMTR, EUROCORD AND EBMT COLLABORATIVE ANALYSIS

F. Baron, B. Sandmaier, M. Labopin, 2016, Leukemia.

J. Wagner, S. Davies, D. Weisdorf, 1997, British journal of haematology.

Feasibility and timing of unrelated donor identification for patients with ALL.

S. Davies, D. Weisdorf, N. Ramsay, 1996, Bone marrow transplantation.

The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.

R. Vij, M. Aljurf, J. Szer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.

H. Kohrt, R. Vij, M. Aljurf, 2012, Blood.

Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients

J. Wagner, D. Weisdorf, M. Verneris, 2009, Bone Marrow Transplantation.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, J. Klein, M. Horowitz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

E. Estey, B. Sandmaier, M. Krem, 2021, Bone Marrow Transplantation.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.

M. Horowitz, V. Paton, D. Weisdorf, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In vitro correlates of low dose Ara‐C efficacy: Clinical, cytogenetic, and bone marrow culture analysis

M. Oken, D. Arthur, D. Weisdorf, 1987, American journal of hematology.

Circulating bacterial DNA and neutropenic fever during anti‐leukaemia chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2020, British Journal of Haematology.

How old is too old for a transplant?

D. Weisdorf, 2021, Best practice & research. Clinical haematology.

Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma.

D. Weisdorf, J. Kersey, F. Cervantes, 1995, Bone marrow transplantation.

Genomics of clonal evolution in a case of essential thrombocythemia

M. Linden, D. Weisdorf, A. Rashidi, 2018, Leukemia & lymphoma.

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

M. Horowitz, M. Bishop, Carole B. Miller, 2008, Bone Marrow Transplantation.

Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia.

S. Sallan, J. Ritz, M. Steinbuch, 1997, Blood.

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.

J. Ledbetter, F. Uckun, D. Weisdorf, 1990, Blood.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

P. Parham, J. Wagner, Jeffrey S. Miller, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adaptive NK cell and KIR-expressing T cell responses are induced by CMV and are associated with protection against CMV reactivation after allogeneic donor hematopoietic cell transplantation Blood Marrow Transplant .

P. Parham, J. Wagner, D. Weisdorf, 2015 .

This information is current as Response to Recipient CMV Antigen Transplantable and Expand In Vivo in NK Cells Are + Memory-like NKG 2 C Human Cytomegalovirus ( CMV )-Induced Anasetti

Jeffrey S. Miller, D. Weisdorf, C. Anasetti, 2012 .

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011, Blood.

recovery of cytokine-producing and cytotoxic functions NK cell education after allogeneic transplantation : dissociation between

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011 .

Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.

D. Weisdorf, B. Blazar, T. DeFor, 2020, Blood advances.

Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition

Bin Zhang, Jeffrey S. Miller, J. Ross, 2013, Clinical Cancer Research.

Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Transfusion.

Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients.

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.

H. Deeg, T. Fleming, J. Dipersio, 2007, Blood.

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

T. Braun, J. Bolaños-Meade, E. Holler, 2015, The Lancet. Haematology.

Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials.

G. Colditz, B. Sandmaier, J. Dipersio, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-host disease treatment: predictors of survival.

J. Bolaños-Meade, Juan Wu, D. Weisdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity versus myeloablative allogeneic transplantation.

D. Weisdorf, 2017, Hematology/oncology and stem cell therapy.

Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation.

D. Weisdorf, B. Blazar, J. Kersey, 1994, Transplantation.

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.

D. Weisdorf, B. Blazar, J. Kersey, 1992, Bone marrow transplantation.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

New classification of chronic GVHD: added clarity from the consensus diagnoses

J. Witte, M. MacMillan, D. Weisdorf, 2009, Bone Marrow Transplantation.

Assessing surge capacity for radiation victims with marrow toxicity.

M. Davids, D. Weinstock, J. Chute, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Healthcare resource utilization and costs among patients with steroid-resistant chronic graft-versus-host disease in the United States: a retrospective claims database analysis

D. Weisdorf, S. Parasuraman, Jingbo Yu, 2021, Current medical research and opinion.

Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2018, American journal of hematology.

A Phase I/II Randomized, Placebo-Control Trial of Palifermin to Prevent Graft-Versus- Host Disease (GVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Running head: Palifermin to prevent GVHD

T. Braun, D. Weisdorf, B. Blazar, 2006 .

The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.

D. Weisdorf, J. Villablanca, M. Steiner, 1990, Bone marrow transplantation.

CXCR4 expression in CD34+ cells and unit predominance after double umbilical cord blood transplantation

J. Wagner, C. Eide, D. Weisdorf, 2013, Leukemia.

The Spectrum of Non-Candida Fungal Infections following Bone Marrow Transplantation

V. Morrison, D. Weisdorf, R. Haake, 1993, Medicine.

History and Current Status of Hematopoietic Cell Transplantation

D. Weisdorf, R. Mehta, 2019, Hematopoietic Cell Transplantation for Malignant Conditions.

Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation.

D. Weisdorf, A. Rashidi, R. Shanley, 2020, Blood advances.

Haptoglobin genotype and gut barrier-related complications of allogeneic hematopoietic cell transplantation

D. Weisdorf, A. Rashidi, T. Allen, 2019, Bone Marrow Transplantation.

Post-transplant complications Acquired factor VII deficiency in hematopoietic stem cell transplant recipients

D. Weisdorf, A. Toor, A. Slungaard, 2002 .

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703

W. Wood, Bryce Waldman, Z. DeFilipp, 2020 .

Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplant serum citrulline predicts acute graft-versus-host disease

A. Khoruts, D. Weisdorf, B. Blazar, 2018 .

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

J. Klein, P. Parham, Jeffrey S. Miller, 2007 .

Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.

D. Weisdorf, M. Solh, S. Morgan, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2016 .

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.

J. L. Goodman, M. MacMillan, D. Weisdorf, 2002, The American journal of medicine.

Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis.

D. Weisdorf, V. Roy, L. Ochs, 1997, Leukemia & lymphoma.

Prophylactic antibiotics for the prevention of early infection in multiple myeloma.

M. Oken, J. Bennett, D. Weisdorf, 1996, The American journal of medicine.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Jeffrey S. Miller, M. MacMillan, Juan Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.

R. Collins, J. Fay, J. Wingard, 1996, Blood.

Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study

S. Bhatia, D. Weisdorf, M. Arora, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is it time for a new look at granulocyte transfusions?

D. Weisdorf, J. V. van Burik, Jo‐Anne H. Van Burik, 2002, Transfusion.

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL.

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2019, Blood advances.

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

C. Craddock, V. Brown, C. Hourigan, 2022, Leukemia.

Comparison of IPSS and IPSS-R Scoring in a Population Based Myelodysplastic Syndromes (MDS) Study

Jeffrey S. Miller, J. Ross, B. Hirsch, 2012 .

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

J. Sierra, J. Dipersio, M. Tallman, 2008 .

STREPTOCOCCAL SEPSIS IN BONE MARROW TRANSPLANT PATIENTS

B. Bostrom, D. Weisdorf, J. Kersey, 1984, The Lancet.

Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.

A. McKinney, D. Weisdorf, Q. Cao, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B‐Cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, D. Weisdorf, 2017, Cancer.

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

M. Tallman, R. Gale, T. Shea, 2015, Bone Marrow Transplantation.

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Flowers, 2015, Haematologica.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

S. Tarima, O. Ringdén, P. McCarthy, 2011, Bone Marrow Transplantation.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

H. Atkins, P. Hari, A. Dispenzieri, 2010, Clinical lymphoma, myeloma & leukemia.

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

M. Horowitz, D. Weisdorf, J. D. Rizzo, 2012 .

MUCOSITIS AND α-STREPTOCOCCAL SEPSIS IN BONE MARROW TRANSPLANT RECIPIENTS

B. Bostrom, D. Weisdorf, 1984, The Lancet.

J. Wagner, S. Davies, D. Weisdorf, 1996, Leukemia & lymphoma.

Future of cord blood for oncology uses

D. Weisdorf, C. Brunstein, 2009, Bone Marrow Transplantation.

High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, W. Kiffmeyer, 2003, Transplantation.

Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.

D. Weisdorf, M. Arora, A. Rashidi, 2021, Transplantation and cellular therapy.

Trends in Late Mortality and Life Expectancy After Autologous Blood or Marrow Transplantation Over Three Decades: A BMTSS Report

S. Bhatia, D. Weisdorf, M. Arora, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FK 506 ( Tacrolimus ) Monotherapy for Prevention of Graft-Versus-Host Disease After Histocompatible Sibling Allogeneic Bone Marrow Transplantation

R. Collins, J. Fay, J. Wingard, 2002 .

COVID19 seroconversion in an unrelated stem cell donor

S. Devine, D. Weisdorf, M. Arora, 2020, Bone Marrow Transplantation.

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation.

Robin R. Shields-Cutler, Gabriel A. Al-Ghalith, D. Knights, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Does high‐dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

P. Valent, W. Sperr, D. Weisdorf, 2013, American journal of hematology.

Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation

P. Anderson, D. Weisdorf, A. Filipovich, 1991 .

Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.

P. Anderson, D. Weisdorf, A. Filipovich, 1991, Blood.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

B. Sandmaier, M. Horowitz, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Wagner, T. Singleton, D. Weisdorf, 2013 .

J. Wagner, T. Singleton, D. Weisdorf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia.

D. Weisdorf, M. Verneris, V. Bachanova, 2011, Blood.

Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD 20 expression in acute lymphoblastic leukemia

D. Weisdorf, M. Verneris, V. Bachanova, 2011 .

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

D. Weisdorf, D. Marks, Mei-Jie Zhang, 2008 .

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2019, Blood advances.

Cytokine expression in human cutaneous chronic graft-versus-host disease.

D. Weisdorf, B. Blazar, L. Ochs, 1996, Bone marrow transplantation.

Response to thalidomide therapy in refractory chronic graft-versus-host disease

J. Wagner, S. Davies, D. Weisdorf, 2000, Bone Marrow Transplantation.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

J. Wagner, D. Weisdorf, J. Miller, 2009, Bone Marrow Transplantation.

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Blood.

Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure

J. Wagner, J. Tolar, D. Weisdorf, 2015, American journal of hematology.

Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.

S. Davies, D. Weisdorf, B. Blazar, 1994, Bone marrow transplantation.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

A survey of diagnosis, management, and grading of chronic GVHD.

M. Horowitz, Stephanie J. Lee, M. Flowers, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients.

D. Weisdorf, T. DeFor, J. V. van Burik, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.

D. Weisdorf, W. Miller, R. Haake, 1994, Bone marrow transplantation.

ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival

M. Steinbuch, D. Weisdorf, A. Filipovich, 1997, Annals of Hematology.

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children

W. Woods, D. Weisdorf, J. Kersey, 1988, British journal of haematology.

Allogeneic transplantation for advanced acute leukemia.

D. Weisdorf, 2022, Hematology. American Society of Hematology. Education Program.

Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.

B. Bostrom, D. Weisdorf, J. Kersey, 1990, Bone marrow transplantation.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New Strategies for Fungal Infections after Hematopoietic Cell Transplantation : Prevention or Preemption ?

Treasurer, H. Heslop, R. Soiffer, 2007 .

INTERLEUKIN 2 IMMEDIATELY AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA–A PHASE I STUDY

P. Anderson, F. Uckun, D. Weisdorf, 1993, Transplantation.

Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients.

D. Weisdorf, B. Oran, C. Brunstein, 2009 .

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

C. Verfaillie, J. Lebkowski, D. Weisdorf, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Core‐binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure

C. Bloomfield, K. Mrózek, M. Perales, 2020, International journal of laboratory hematology.

A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics

A. Khoruts, C. Staley, D. Weisdorf, 2022, PloS one.

Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome

W. Woods, F. Uckun, D. Weisdorf, 1994, British journal of haematology.

Chronic graft-versus-host disease: where is promise for the future?

D. Weisdorf, D. Weisdorf, 2005, Leukemia.

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

M. Perales, F. Appelbaum, D. Porter, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemia

D. Arthur, D. Weisdorf, J. Kersey, 1984 .

Hematopoietic Cell and Solid Organ Transplantation in the same patient: Long term experience at the University of Minnesota: Combined Hematopoietic and Solid Organ Transplantation.

T. Pruett, D. Weisdorf, T. DeFor, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation.

J. Wagner, S. Davies, D. Weisdorf, 1996, Bone marrow transplantation.

J. Ledbetter, F. Uckun, D. Weisdorf, 1992 .

Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.

E. Dubberke, M. Horowitz, J. Wingard, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia

D. Weisdorf, A. Rashidi, S. Gilles, 2018, Leukemia.

IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice.

D. Weisdorf, B. Blazar, M. Widmer, 1996, Transplantation.

Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

P. Hari, M. Pasquini, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

D. Kaufman, D. Weisdorf, T. DeFor, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Identification and Purification of the Human Myeloid Differentiation Antigen Recognized by Monoclonal Antibody AHN‐7

J. August, D. Weisdorf, K. Skubitz, 1987, Journal of leukocyte biology.

Measurement of bleeding severity: a critical review

C. Weinert, D. Weisdorf, N. Key, 2004, Transfusion.

1994 Consensus Conference on Acute GVHD Grading.

E D Thomas, D. Weisdorf, E. Thomas, 1995, Bone marrow transplantation.

Infections in Recipients of Hematopoietic Stem Cell Transplants

D. Weisdorf, Jo-Anne H. Young, 2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases.

GASTRIC RECURRENCE OF ACUTE LYMPHOBLASTIC LEUKAEMIA MIMICKING GRAFT‐VERSUS‐HOST DISEASE

D. Arthur, D. Snover, D. Weisdorf, 1989, British journal of haematology.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients

S. Bhatia, D. Weisdorf, M. Arora, 2022, Bone Marrow Transplantation.

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study

L. Robison, S. Bhatia, J. Gurney, 2006, Bone Marrow Transplantation.

Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report

J. A. Watson, S. Bhatia, D. Weisdorf, 2019, Cancer.

Comorbidity burden in patients with chronic GVHD

W. Wood, B. Storer, J. Pidala, 2013, Bone Marrow Transplantation.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Blood.

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

K. Ness, S. Bhatia, J. Gurney, 2005, Blood.

L. Robison, S. Bhatia, J. Gurney, 2004 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Daniel Wolff, Yoshihiro Inamoto, Sandra A Mitchell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

A. Nademanee, Yan Liu, L. Robison, 2005, Blood.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

R. Gale, M. Bishop, O. Ringdén, 2011, Bone Marrow Transplantation.

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

B. Sandmaier, M. Horowitz, H. Khoury, 2017, Cancer.

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

R. Vij, M. Perales, F. Appelbaum, 2015, Blood.

Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.

M. Pasquini, U. Popat, V. Bhatt, 2020, Blood advances.

Hematopoietic Cell Transplant Related Toxicities and Mortality in Frail Recipients.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

M. Horowitz, P. Armand, R. Soiffer, 2014, Blood.

Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

J. Klein, M. Horowitz, R. Gale, 2006, British journal of haematology.

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.

F. Uckun, D. Weisdorf, J. Kersey, 1993, The New England journal of medicine.

Lenalidomide after stem-cell transplantation for multiple myeloma.

K. Owzar, C. Hofmeister, R. Vij, 2012, The New England journal of medicine.

Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation

D. Weisdorf, S. Parasuraman, Jingbo Yu, 2019, Current medical research and opinion.

Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.

D. Weisdorf, J. Kersey, N. Ramsay, 1993, Transplantation.

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.

V. Morrison, D. Weisdorf, R. Haake, 1994, The American journal of medicine.

Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 1995, Blood.

Candida infections in bone marrow transplant recipients.

C. Verfaillie, D. Weisdorf, M. Hostetter, 1991, Bone marrow transplantation.

Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.

R A Nash, J. Fay, J. Wingard, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease: a prospective cohort study.

M. MacMillan, S. Davies, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

J. Wagner, C. Verfaillie, Jeffrey S. Miller, 2001, The American journal of medicine.

Management of graft-versus-host disease.

D. Weisdorf, 1994, Transfusion science.

Pneumocystis carinii pneumonitis following bone marrow transplantation.

D. Weisdorf, D. Dennison, I. Z. Tuan, 1992, Bone marrow transplantation.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2018, Blood advances.

CMV antigenemia following bone marrow transplantation: risk factors and outcomes.

R. Osarogiagbon, D. Weisdorf, A. Erice, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

J. Wagner, J. Tolar, D. Weisdorf, 2006, Blood.

Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

J. Wagner, J. Kurtzberg, M. Trigg, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

J. Wagner, S. Davies, D. Weisdorf, 2001, Blood.

Transplants for leukemia in relapse: when is the best time?

D. Weisdorf, 2011, Best practice & research. Clinical haematology.

More Infections with Transplantation of Bone Marrow, Versus Peripheral-Blood Stem Cells, from Unrelated Donors

M. Horowitz, J. Wingard, Juan Wu, 2015 .

Acute Myeloid Leukemia.

Daniel J Weisdorf, Hartmut Döhner, C. Bloomfield, 2015, The New England journal of medicine.

BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

G. Papanicolaou, V. Brown, M. Aljurf, 2018, Bone Marrow Transplantation.

Quantitative serum PCR argues against long‐term persistence of HHV‐6 viremia after umbilical cord blood transplantation

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.

C. Walker, D. Weisdorf, J. V. van Burik, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.

Daniel J Weisdorf, D. Weisdorf, T. DeFor, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

C Anasetti, S. Davies, C. Kollman, 2001, Blood.

Infection after Allogeneic ransplantation : Comparison of Cord Blood ith Peripheral Blood and Marrow Graft Sources

C. Walker, D. Weisdorf, J. V. Burik, 2007 .

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2005, Blood.

Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

Todd E DeFor, Daniel J Weisdorf, John E Wagner, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

J. Wagner, M. MacMillan, D. Weisdorf, 2009, Blood.

Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

D. Weisdorf, C. Ustun, Jo-Anne H. Young, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

E. Jaffe, R. Hoover, H. Deeg, 1999, Blood.

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

J. Wagner, F. Appelbaum, K. Ballen, 2010, Blood.

Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, T. DeFor, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Blood.

Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type

D. Weisdorf, C. Cohn, T. DeFor, 2021, Transfusion.

Malignant neoplasms following bone marrow transplantation.

L. Robison, J. Neglia, S. Bhatia, 1996, Blood.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

A. Nademanee, L. Robison, S. Bhatia, 2007, Blood.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

J. Klein, M. Tallman, A. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis

M. Horowitz, B. Shaw, S. Devine, 2020, Biology of Blood and Marrow Transplantation.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

J. Wagner, P. Westervelt, J. Dipersio, 2018, Blood.

Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

P. Parham, Jeffrey S. Miller, S. Marsh, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT

J. Wagner, Bin Zhang, Jeffrey S. Miller, 2015, Leukemia.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

D. Vesole, D. Weisdorf, B. Blazar, 2003, Bone Marrow Transplantation.

Survival for older patients with acute myeloid leukemia: a population-based study

D. Weisdorf, B. Oran, 2012, Haematologica.

HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis.

H. Chu, D. Weisdorf, A. Rashidi, 2019, Blood advances.

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

J. Klein, M. Horowitz, J. Wingard, 2014, Clinical Cancer Research.

Palifermin for oral mucositis after intensive therapy for hematologic cancers

T. Shea, D. Weisdorf, B. Blazar, 2017 .

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

M. Robin, D. Weisdorf, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission.

D. Weisdorf, B. Oran, Q. Cao, 2011, Leukemia research.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

D. Weisdorf, T. DeFor, A. Cioc, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

John P Klein, Daniel J Weisdorf, Ciril Rozman, 2002, Blood.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

D. Weisdorf, R. Gingrich, S. Pavletic, 2005, Blood.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute radiation injury: contingency planning for triage, supportive care, and transplantation.

J. Armitage, D. Weisdorf, N. Chao, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA match likelihoods for Indian patients seeking unrelated donor transplantation grafts: a population-based study.

Martin Maiers, Saranya Narayan, Michael Halagan, 2014, The Lancet. Haematology.

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

M. Horowitz, R. Soiffer, M. Kalaycio, 2013 .

Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

M. Farrar, D. Weisdorf, B. Blazar, 2010, Blood.

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

M. Pasquini, M. Horowitz, J. Wingard, 2009, Blood.

A. Nademanee, W. Wen, D. Weisdorf, 2000, Blood.

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.

N. Geller, A. Krishnan, P. Hari, 2011, The Lancet. Oncology.

Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2017, Blood advances.

Hemolytic uremic syndrome following bone marrow transplantation.

D. Weisdorf, M. Juckett, E. Perry, 1991, Bone marrow transplantation.

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Daniel J Weisdorf, John E Wagner, J. Wagner, 2002, Blood.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Harriet Noreen, Marcelo Fernandez-Vina, John Klein, 2007, Blood.

Reduced Relapse and Similar Progression-Free Survival After Double Umbilical Cord Blood Transplantation (DUCBT): Comparison of Outcomes Between Sibling, Unrelated Adult and Unrelated DUCB Hematopoietic Stem Cell (HSC) Donors.

J. Wagner, F. Appelbaum, T. Gooley, 2009 .

Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease

D. Weisdorf, R. Mehta, Q. Cao, 2017, Bone Marrow Transplantation.

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.

S. Devine, D. Weisdorf, B. Logan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

A I Goldman, B Bostrom, W. Woods, 1987, The New England journal of medicine.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

Juan Wu, D. Weisdorf, B. Logan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Levaquin gets a pass.

A. Khoruts, C. Staley, D. Weisdorf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

D. Weisdorf, R. Remmel, P. Jacobson, 2005, Clinical pharmacology and therapeutics.

A Limited Sampling Model for Estimation of Total and Unbound Mycophenolic Acid (MPA) Area Under the Curve (AUC) in Hematopoietic Cell Transplantation (HCT)

D. Weisdorf, P. Jacobson, J. Ng, 2006, Therapeutic drug monitoring.

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods,

J. Vose, J. Radich, N. Kröger, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation for acute lymphocytic leukemia.

W. Woods, T. Lebien, D. Weisdorf, 1985, Seminars in oncology.

Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia.

D. Weisdorf, A. Rashidi, 2020, Translational research : the journal of laboratory and clinical medicine.

phase I/II clinical trial Interleukin-1 alpha administered after autologous transplantation: a

C. Verfaillie, D. Weisdorf, B. Blazar, 2011 .

Anti-CD3 + interleukin-2 stimulation of marrow and blood: comparison of proliferation and cytotoxicity.

P. Anderson, D. Weisdorf, N. Ramsay, 1992, Blood.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.

P. Hari, M. Pasquini, M. Qazilbash, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

Colleen Delaney, Claudio G Brunstein, Daniel J Weisdorf, 2010, Blood.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2008, Blood.

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

marrow from unrelated donors: the effect of donor age Donor characteristics as risk factors in recipients after transplantation of bone

S. Davies, C. Kollman, D. Weisdorf, 2013 .

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

D. Weisdorf, V. Bachanova, Q. Cao, 2016, Bone Marrow Transplantation.

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

J. Klein, P. Parham, Jeffrey S. Miller, 2014, The Journal of Immunology.

marrow purging complement and 4- hydroperoxycyclophosphamide for ex vivo bone monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus B-lineage acute lymphoblastic leukemia using a cocktail of three Autologous bone marrow transplantation in high-risk remission

F. Uckun, D. Weisdorf, N. Ramsay, 2011 .

Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time.

J. Wagner, D. Weisdorf, C. Ustun, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

J. Goldberg, B. Kurland, J. Pidala, 2014, Arthritis & rheumatology.

Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's Lymphoma

J. Leonard, J. Hainsworth, S. Horning, 2007, Clinical Cancer Research.

Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis.

D. Weisdorf, H. Jacob, P. Craddock, 1982, Blood.

Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.

J. Wagner, M. Steinbuch, S. Davies, 1996, Bone marrow transplantation.

Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission.

W. Woods, G. Vercellotti, B. Bostrom, 1988, Blood.

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

J. Dipersio, M. Tallman, R. Gale, 2010, Blood.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

R. Schlenk, H. Döhner, A. Ganser, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

M. Horowitz, M. Tallman, R. Gale, 2000, Blood.

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.

J. Armitage, J. Klein, S. Piantadosi, 2001, Experimental hematology.

Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation

J. Wagner, G. Vercellotti, D. Weisdorf, 2013, Bone Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.

D. Weisdorf, W. Thomas, T. DeFor, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.

D. Weisdorf, A. Dudek, T. DeFor, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myelodysplastic syndrome after autologous transplant for lymphoma [7]

J. Vose, James R. Anderson, A. Kessinger, 1994 .

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.

C. Le, J. Wagner, B. Levine, 2016, Blood.

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

A. Nademanee, J. Fay, R. Storb, 1998, Blood.

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

A. Gratwohl, J. Szer, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

No evidence for colonization of oral bacteria in the distal gut in healthy adults

C. Staley, D. Weisdorf, M. Costalonga, 2021, Proceedings of the National Academy of Sciences.

Risk of COVID-19 Infection in Long-term Survivors of Blood or Marrow Transplantation: A BMTSS Report

D. Weisdorf, S. Forman, W. Landier, 2023, Blood Advances.

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

S. Bhatia, D. Weisdorf, S. Forman, 2011, Blood.

Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study.

K. Ness, L. Robison, S. Bhatia, 2004, Blood.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.

M. Horowitz, D. Weisdorf, M. Arora, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.

J. Wagner, Jeffrey S. Miller, R. Vogel, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.

S. Davies, D. Weisdorf, B. Blazar, 1994, Bone marrow transplantation.

Successful allogeneic cryopreserved marrow transplantation

D. Weisdorf, B. Blazar, J. Kersey, 1989, Transfusion.

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

A. Gratwohl, M. Aljurf, J. Szer, 2013, Bone Marrow Transplantation.

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.

D. Neuberg, R. Soiffer, Stephanie J. Lee, 2002, Blood.

Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol.

M. Horowitz, J. Wingard, R. Soiffer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial

J. Wagner, K. Dusenbery, M. MacMillan, 2000, British journal of haematology.

Searching for unrelated donor hematopoietic stem cells

J. Wagner, S. Davies, D. Weisdorf, 2002 .

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen

Jeffrey S. Miller, D. Weisdorf, C. Anasetti, 2012, The Journal of Immunology.

The Graying of Clinical Transplantation

Treasurer, H. Heslop, R. Soiffer, 2006 .

S. Spellman, M. Setterholm, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Factors Predicting Single-Unit Predominance after Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2011, Bone Marrow Transplantation.

Transplant Survivor Study functional status of long-term survivors: report from the Bone Marrow Late mortality after allogeneic hematopoietic cell transplantation and

A. Nademanee, L. Robison, S. Bhatia, 2011 .

Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

M. MacMillan, D. Weisdorf, C. Ustun, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.

J. Wagner, J. Tolar, K. Robien, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

Pediatric acute GVHD: clinical phenotype and response to upfront steroids

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Bone Marrow Transplantation.

Validation of Minnesota acute graft-versus-host disease Risk Score

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Haematologica.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Therapeutic Cyclosporine Levels Early Post-Transplantation Reduces Risks of Acute Graft-Versus-Host Disease and Improves Survival

D. Weisdorf, B. Blazar, M. Arora, 2013, Bone Marrow Transplantation.

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.

J. Wagner, M. Horowitz, J. Wingard, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

J. Wagner, Priya Kumar, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Potentially inappropriate medications in geriatric blood or marrow transplantation (BMT) survivors: A BMT Survivor Study report

S. Bhatia, D. Weisdorf, S. Forman, 2022, Cancer.

Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.

J. Hicks, S. Bhatia, D. Weisdorf, 2021, JAMA oncology.

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?

J. Wagner, M. Perales, H. Lazarus, 2019, Haematologica.

Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.

K. Ness, S. Bhatia, D. Weisdorf, 2016, JAMA oncology.

Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

S. Bhatia, D. Weisdorf, J. Kersey, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

M. Robin, M. Pasquini, Richard J. Jones, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

M. MacMillan, D. Weisdorf, T. DeFor, 2012, British journal of haematology.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid

A. Khoruts, C. Forster, M. MacMillan, 2018, Modern Pathology.

Pharmacogenetics of steroid‐responsive acute graft‐versus‐host disease

D. Weisdorf, M. Arora, B. Thyagarajan, 2017, Clinical transplantation.

The best endpoint for acute GVHD treatment trials.

M. MacMillan, D. Weisdorf, T. DeFor, 2010, Blood.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium

B. Kurland, J. Pidala, M. Flowers, 2013, Bone Marrow Transplantation.

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

M. Caligiuri, C. Lengerke, B. Becher, 2018, Nature Medicine.

Treatment of relapsed/refractory acute myeloid leukaemia in adults

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, British journal of haematology.

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors.

J. Wagner, D. Weisdorf, D J Weisdorf, 2001, The New England journal of medicine.

The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia

M. Perales, M. Territo, D. Weisdorf, 2017, Haematologica.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.

J. Wagner, K. Ballen, R. Soiffer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010 .

The effect of equine antithymocyte globulin on the outcomes of reduced intensity conditioning for AML

J. Wagner, D. Weisdorf, T. DeFor, 2014, Bone Marrow Transplantation.

Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case

D. Weisdorf, N. Majhail, R. Romee, 2010, Bone Marrow Transplantation.

Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model

S. Bhatia, D. Weisdorf, M. Arora, 2021, Blood advances.

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Blood advances.

Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.

J. Wagner, D. Weisdorf, D. Hurd, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Determinants of survival after human leucocyte antigen‐matched unrelated donor bone marrow transplantation in adults

Jeffrey S. Miller, S. Davies, D. Weisdorf, 2002, British journal of haematology.

bone marrow : results of a matched-pair analysis matched unrelated donor − comparable to that of human leukocyte antigen Survival after transplantation of unrelated donor umbilical cord blood

J. Wagner, S. Davies, D. Weisdorf, 2001 .

THE TISSUE EXPRESSION OF CYTOKINES IN HUMAN ACUTE CUTANEOUS GRAFT‐VERSUS‐HOST DISEASE

D. Weisdorf, B. Blazar, L. Ochs, 1995, Transplantation.

Patient interleukin‐18 GCG haplotype associates with improved survival and decreased transplant‐related mortality after unrelated‐donor bone marrow transplantation

J. Bidwell, M. MacMillan, D. Weisdorf, 2004, British journal of haematology.

Interleukin‐1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia

J. Klein, M. MacMillan, S. Davies, 2007, British journal of haematology.

Complement fragment 3a priming of umbilical cord blood progenitors: safety profile.

J. Wagner, M. Ratajczak, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduction in late mortality among patients with Multiple Myeloma treated with Autologous Peripheral Blood Stem Cell Transplantation - a BMTSS Report.

S. Bhatia, D. Weisdorf, M. Arora, 2021, Transplantation and cellular therapy.

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma

Scott E. Smith, Sin-Ho Jung, K. Owzar, 2017, The Lancet. Haematology.

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium

B. Kurland, J. Pidala, Stephanie J. Lee, 2011, Haematologica.

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.

R. Larson, M. Perales, A. Nagler, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement

F. Prósper, B. Ness, C. Verfaillie, 1997, Leukemia.

Costs of pediatric allogeneic hematopoietic‐cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2010, Pediatric blood & cancer.

Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells Comparative Analysis of Autografting in Chronic Myelogenous Leukemia

C. Verfaillie, Jeffrey S. Miller, M. Steinbuch, 2010 .

Comparative Analysis of Autografting in Chronic Myelogenous Leukemia: Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells

C. Verfaillie, Jeffrey S. Miller, M. Steinbuch, 1998 .

Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.

C. Verfaillie, M. Steinbuch, B. Hirsch, 1998, Blood.

Autologous Bone Marrow Transplantation for Patients With Acute Lymphoblastic Leukemia in Second or Subsequent Remission : Results of Bone Marrow Treated With Monoclonal Antibodies BAi BAi BAi , BA2 BA2 BA2 , and BA3 BA3 BA3 Plus Complement By

T. Kim, D. Weisdorf, D. Hurd, 2005 .

Goldman, Philip, D. Weisdorf, 2005 .

Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2021, Transplantation and cellular therapy.

Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Necessity for treatment of steroid refractory severe GIT GVHD: patience of providers

D. Weisdorf, A. Rashidi, C. Ustun, 2019, Bone Marrow Transplantation.

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.

S. Zeger, G. Gui, C. Hourigan, 2023, JAMA.

Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

S. Devine, D. Weisdorf, B. Logan, 2015 .

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.

C. Le, J. Wagner, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

J. Vose, J. Fay, S. Bhatia, 2003, Blood.

Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?

D. Weisdorf, A. Blaes, S. Konety, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.

P. Hari, P. Watry, J. Snowden, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative HPC transplantation

D. Weisdorf, T. Repka, 2000, Transfusion.

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma

J. Wagner, D. Weisdorf, J. Miller, 2007, Bone Marrow Transplantation.

6: Risk of Relapse after Umbilical Cord Blood Transplantation in Patients with Acute Leukemia: Marked Reduction in Recipients of Two Units

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.

D. Weisdorf, B. Blazar, J. Kersey, 1993, Bone marrow transplantation.

P. Bierman, E. Montserrat, K. Ballen, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia

M. Oken, D. Weisdorf, R. Rydell, 1983, British journal of haematology.

Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia

J. Klein, M. Horowitz, R. Gale, 2000 .

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns.

M. Tallman, D. Weisdorf, Vikas Gupta, 2011, Blood.

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.

D. Weisdorf, J. Ferrara, D. Confer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation

J. Wagner, C. Verfaillie, K. Dusenbery, 2000, Bone Marrow Transplantation.

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

J. Wagner, S. Spellman, M. Setterholm, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.

J. Wagner, C. Verfaillie, M. Steinbuch, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

Peritransplant palifermin use and lymphocyte recovery after T‐cell replete, matched related allogeneic hematopoietic cell transplantation

D. Weisdorf, B. Blazar, M. Verneris, 2011, American journal of hematology.

Lupus inhibitors following bone marrow transplant.

C. Verfaillie, D. Weisdorf, P. Mcglave, 1995, Bone marrow transplantation.

Bone marrow transplantation: what you need to know

D. Weisdorf, 1990 .

Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.

M. Horowitz, K. Rai, R. Gale, 1999, Leukemia research.

Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation

D. Weisdorf, S. Parasuraman, Jingbo Yu, 2020, Supportive Care in Cancer.

Isolated relapse of acute myelogenous leukemia presenting as a gastric ulcer

G. Vercellotti, D. Snover, D. Weisdorf, 1991, American journal of hematology.

Radiologic and nuclear events: contingency planning for hematologists/oncologists.

Judith L Bader, Daniel J Weisdorf, David M Weinstock, 2008, Blood.

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010, Bone Marrow Transplantation.

Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01

Wesley M. Marin, P. Parham, Jeffrey S. Miller, 2021, The Journal of Immunology.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Low 5-year health care burden after umbilical cord blood transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Blood advances.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

M. Caligiuri, A. Velardi, S. Farag, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gut microbiota response to antibiotics is personalized and depends on baseline microbiota

A. Khoruts, C. Staley, D. Weisdorf, 2021, Microbiome.

Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis

P. Parham, Stephanie J. Lee, S. Spellman, 2019 .

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

K. Hsu, Stephanie J. Lee, O. Ringdén, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelogenous Leukemia Unrelated Transplantation for Acute Mismatch Enhance the Clinical Benefit of Haplotypes, Recipient HLA-C1, and HLA-C Donor Killer Cell Ig-like Receptor B

Martha, Jeffrey, J. Klein, 2014 .

Stress responses , M 2 macrophages , and a distinct microbial signature in fatal intestinal acute graft-versus-host disease

A. Khoruts, M. MacMillan, D. Weisdorf, 2019 .

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016, Current topics in microbiology and immunology.

cells is improved using IL-2 diphtheria toxin fusion protein Clearance of acute myeloid leukemia by haploidentical natural killer

Bin Zhang, D. Weisdorf, B. Blazar, 2014 .

Radiation Emergencies: Evaluation, Management, and Transplantation

J. Wingard, D. Weisdorf, N. Chao, 2007 .

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Avis J. Thomas, D. Kaufman, J. Wagner, 2007 .

Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

M. Cazzola, H. Deeg, P. Greenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

B. Storer, J. Pidala, Stephanie J. Lee, 2014, Haematologica.

Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD

W. Wood, J. Pidala, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Haematologica.

Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease

D. Weisdorf, M. Ewell, S. Yanovich, 2005, Bone Marrow Transplantation.

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

M. Linden, D. Weisdorf, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation.

M. Oken, J. Glick, D. Weisdorf, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance.

D. Weisdorf, P. Ferrieri, Jo-Anne H. Young, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation

R. Porcher, M. Robin, A. Toubert, 2012, Transplantation.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey.

D. Weisdorf, E. Gluckman, M. Eapen, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors

J. Wagner, D. Weisdorf, N. Majhail, 2012, Bone Marrow Transplantation.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

J. Klein, M. Horowitz, J. Wingard, 2011, Blood.

Digital integration of granulocyte aggregation responses

D. Weisdorf, D. Hammerschmidt, P. Craddock, 1980, Inflammation.

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.

A I Goldman, W. Woods, D. Weisdorf, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

N. Kröger, D. Porter, C. June, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis.

J. Platt, D. Snover, D. Weisdorf, 1991, Bone marrow transplantation.

Influence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

K. Dusenbery, D. Weisdorf, T. DeFor, 2019, International journal of radiation oncology, biology, physics.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.

D. Heitjan, P. Hari, R. Kyle, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical benefit of response in chronic graft-versus-host disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tacrolimus pharmacokinetics in BMT patients

J. Fay, J. Wingard, R. Nash, 1998, Bone Marrow Transplantation.

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

P. Hari, R. Kyle, D. Reece, 2009, Leukemia.

Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.

J. Pidala, Stephanie J. Lee, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Follow-up of Adults with Acute Lymphoblastic Leukemia in First Remission Treated with Chemotherapy or Bone Marrow Transplantation

E. Thiel, J. Klein, K. Sobocinski, 1995, Annals of Internal Medicine.

Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, E. Chiorean, D. Weisdorf, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synopsis of Partial-Body Radiation Diagnostic Biomarkers and Medical Management of Radiation Injury Workshop

Ronald E. Goans, William F. Blakely, Andrzej Wojcik, 2010, Radiation research.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

New Guidelines Help Health Professionals Recognize and Manage Late Complications

Treasurer, H. Heslop, R. Soiffer, 2006 .

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

K. Dusenbery, D. Weisdorf, M. Verneris, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy.

G. Storme, K. Dusenbery, D. Weisdorf, 2013, International journal of radiation oncology, biology, physics.

Phase III Study Comparing Methotrexate and Tacrolimus ( Prograf , FK 506 ) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

A. Nademanee, J. Fay, R. Storb, 1998 .

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients.

D. Weisdorf, T. DeFor, L. Burns, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.

D. Weisdorf, M. Verneris, V. Bachanova, 2009, Blood.

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

J. Szer, M. Tallman, K. Ballen, 2013, Haematologica.

Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

G. Gui, C. Hourigan, S. Spellman, 2022, Journal of Clinical Oncology.

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

C. Bloomfield, R. Larson, K. Mrózek, 2019, Leukemia.

Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I Trial ofToll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non^Hodgkin’s Lymphoma

J. Leonard, J. Hainsworth, S. Horning, 2007 .

Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2

S. Bhatia, D. Weisdorf, M. Arora, 2018, Leukemia.

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016 .

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

J. Wagner, D. Weisdorf, M. Verneris, 2016, Haematologica.

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302.

J. Bolaños-Meade, Juan Wu, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow Transplant Clinical Trials Network phasecorticosteroids for acute graft-versus-host disease : a randomized Etanercept , mycophenolate , denileukin , or pentostatin plus

M. Pasquini, M. Horowitz, J. Wingard, 2009 .

Impact of Frailty on Hematopoietic Cell on Early Transplant Outcomes in Older Recipients

S. Bhatia, D. Weisdorf, M. Arora, 2015 .

Validation of measurement scales in ocular graft-versus-host disease.

B. Kurland, J. Pidala, Stephanie J. Lee, 2012, Ophthalmology.

Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation.

D. Weisdorf, C. Schiffer, N. Majhail, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pediatric‐inspired therapy compared to allografting for Philadelphia chromosome‐negative adult ALL in first complete remission

D. Neuberg, S. Sallan, J. Bergeron, 2016, American journal of hematology.

Infusions of interleukin-1α after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity

D. Weisdorf, B. Blazar, Zhiyi Xu, 1994, Journal of Clinical Immunology.

Prolonged subcutaneous administration of 852A, a novel systemic toll‐like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2012, American journal of hematology.

TRANSPLANTATION Validation and re fi nement of the Disease Risk Index for allogeneic stem cell transplantation

M. Horowitz, P. Armand, R. Soiffer, 2014 .

AMD3100 Combined with Standard Doses of G-Csf Leads to Rapid, Consistent Mobilization of Hematopoietic Progenitor Cells in Patients with Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma.

G. Tricot, M. Territo, P. McCarthy, 2004 .

Steroid sensitive acute GVHD, but not steroid dependent or steroid resistant, results in similar infection risk as no GVHD following allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, M. Arora, 2022, Transplantation and cellular therapy.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2014, Leukemia & lymphoma.

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

M. MacMillan, D. Weisdorf, M. Arora, 2007 .

CMV Triplex vaccine to enhance adaptive NK and T-cell reconstitution after autologous hematopoietic cell transplantation.

D. Weisdorf, A. Rashidi, D. Diamond, 2022, Transplantation and cellular therapy.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2019, JCI insight.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants

M. Gross, S. Basu, D. Weisdorf, 2013, International journal of immunogenetics.

Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML

E. Tholouli, N. Russell, J. Byrne, 2020, Bone Marrow Transplantation.

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

P. Westervelt, M. Pasquini, M. Horowitz, 2014, Blood.

GTB-3550 TriKE™ for the Treatment of High-Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML) Safely Drives Natural Killer (NK) Cell Proliferation At Initial Dose Cohorts

Jeffrey S. Miller, D. Weisdorf, D. Vallera, 2020 .

Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.

J. Szer, M. Tallman, J. Rowe, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

Robin R. Shields-Cutler, A. Khoruts, C. Staley, 2019, Scientific Reports.

Infection Followed by Graft-versus-Host Disease: Pathogenic Role of Antibiotics.

A. Khoruts, D. Weisdorf, A. Rashidi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of COVID-19 precautions on the gut microbiota and nosocomial infections

A. Khoruts, C. Staley, D. Weisdorf, 2021, Gut microbes.

Autologous Vs. Unrelated Donor Bone Marrow Transplantation for Acute Lymphoblastic Leukemia: Considerations and Logistics

D. Weisdorf, 1996 .

Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.

W. Woods, F. Uckun, B. Bostrom, 1990, Bone marrow transplantation.

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.

D. Weisdorf, T. DeFor, Z. Sachs, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report.

S. Bhatia, D. Weisdorf, M. Arora, 2018, Blood.

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

Kiran R. Vij, M. Linden, D. Weisdorf, 2018, American journal of hematology.

History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

M. Linden, D. Weisdorf, A. Rashidi, 2017, American journal of hematology.

Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation.

D. Weisdorf, B. Logan, Haesook T. Kim, 2021, Transplantation and cellular therapy.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemia.

D. Arthur, D. Weisdorf, J. Kersey, 1984, Blood.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow Transplant Survivor Study hematopoietic cell transplantation survivors: a report from the Bone Impact of chronic graft-versus-host disease on the health status of

K. Ness, S. Bhatia, J. Gurney, 2011 .

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

J. Wagner, D. Douek, M. MacMillan, 2007, Bone Marrow Transplantation.

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Journal of cutaneous pathology.

Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival.

D. Weisdorf, J. Kersey, N. Ramsay, 1995, Bone marrow transplantation.

KIR Ligand Absence in Recipients of Unrelated Donor (URD) Allogeneic Hematopoietic Cell Transplantation (HCT) Is Associated with Less Relapse and Increased Graft Versus Host Disease (GVHD).

J. Klein, P. Parham, M. Horowitz, 2006 .

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

transplantation reduced-intensity conditioning with cord blood or sibling donor Prolonged survival in adults with acute lymphoblastic leukemia after

D. Weisdorf, M. Verneris, V. Bachanova, 2013 .

Prolonged Survival In Adults With Acute Lymphoblastic Leukemia (ALL) Following Reduced Intensity Conditioning With Cord Blood or Sibling Donor Transplantation

D. Weisdorf, M. Verneris, V. Bachanova, 2009 .

D. Weisdorf, N. Majhail, L. Burns, 2009, Bone Marrow Transplantation.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

P. Hari, P. Watry, J. Snowden, 2020, Hematology/oncology and stem cell therapy.

Autoimmune Diseases : When Homeland Security Fails

Treasurer, J. Dipersio, R. Truitt, 2004 .

Comparison of Peripheral Blood Stem Cells (PBSC) to Bone Marrow (BM) for T-Replete HLA-Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

Shannon R. McCurdy, M. Perales, M. Horowitz, 2016 .

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia.

B. Sandmaier, R. Gale, H. Khoury, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, N. Majhail, L. Burns, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.

D. Weisdorf, S. Forman, W. Landier, 2023, JAMA oncology.

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.

T. Lebien, D. Weisdorf, D. Vallera, 1991, Bone marrow transplantation.

Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.

H. Deeg, M. Perales, H. Kluin-Nelemans, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Porcher, M. Robin, P. Chevallier, 2012 .

transplantation comparative analysis of unrelated versus matched sibling donor Allogeneic bone marrow transplantation for chronic myelogenous leukemia

C. Kollman, D. Weisdorf, C. Anasetti, 2013 .

Planning and response to radiation exposures.

D. Weinstock, D. Weisdorf, N. Chao, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

A. Krishnan, P. Hari, D. Maloney, 2017, British journal of haematology.

Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting

R. Vogel, D. Weisdorf, V. Bachanova, 2012, British journal of haematology.

Acute Lymphoblastic Leukemia Autologous Versus Unrelated Donor Allogeneic Marrow Transplantation for

S. Sallan, J. Ritz, M. Steinbuch, 2011 .

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2016, Bone Marrow Transplantation.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Radiation disasters: role of the BMT team.

D. Weinstock, D. Weisdorf, N. Chao, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.

B. George, M. Grunwald, D. Weisdorf, 2021, Blood advances.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

B. Sandmaier, M. Perales, A. Nagler, 2020, Blood advances.

Myeloablative vs. reduced-intensity hematopoietic cell transplantation in myelodysplastic syndromes: a systematic review and meta-analysis.

H. Chu, M. Pasquini, S. Devine, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe, life‐threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood

D. Weisdorf, Yanjun Chen, W. Landier, 2022, Cancer.

enhance engraftment in adults with hematologic malignancy Transplantation of two partially HLA-matched umbilical cord blood units to

J. Wagner, C. Verfaillie, D. Weisdorf, 2009 .

Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Allogeneic stem cell transplantation in first complete remission

D. Weisdorf, B. Oran, 2011, Current opinion in hematology.

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

B. Sandmaier, D. Porter, K. Ballen, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vorinostat is victorious in GVHD prevention.

D. Weisdorf, S. Holtan, 2017, Blood.

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Efficacy of high‐dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma

Jeffrey S. Miller, D. Weisdorf, M. Arora, 2006, American journal of hematology.

PREDNISONE THERAPY FOR ACUTE GRAFT‐VERSUS-HOST DISEASE: SHORT‐VERSUS LONG‐TERM TREATMENT

D. Weisdorf, J. Kersey, A. Filipovich, 1993, Transplantation.

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

J. Sierra, A. Zander, M. Horowitz, 2006, Biology of Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study.

J. Klein, J. Dipersio, M. Tallman, 2009 .

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow

J. Szer, M. Horowitz, Stephanie J. Lee, 2010 .

Can haploidentical transplantation meet all patients' needs?

D. Weisdorf, 2018, Best practice & research. Clinical haematology.

The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study.

H. Baldomero, M. Aljurf, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?

D. Weisdorf, B. Mcclune, 2010, Current opinion in hematology.

Allogeneic hematopoietic cell transplantation in morphologic leukemia‐free aplastic state

P. Westervelt, J. Dipersio, Kiran R. Vij, 2017, American journal of hematology.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Avis J. Thomas, J. Wagner, J. Tolar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A multicenter phase 2 clinical trial of 10-day decitabine, dose-escalated donor lymphocyte infusion, and ruxolitinib for relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic cell transplantation.

J. Dipersio, D. Weisdorf, A. Rashidi, 2023, Transplantation and cellular therapy.

Late-onset Acute and Chronic Graft-Versus-Host Disease in Children: Clinical features and Response to Therapy.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Transplantation and cellular therapy.

Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers

A. Bhatt, D. Weisdorf, A. Rashidi, 2018, American journal of hematology.

THERAPEUTIC RAMIFICATIONS OF THE INTERACTION OF COMPLEMENT, GRANULOCYTES, AND PLATELETS IN THE PRODUCTION OF ACUTE LUNG INJURY *

P. Flynn, G. Vercellotti, D. Weisdorf, 1982, Annals of the New York Academy of Sciences.

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

R. Larson, B. Sandmaier, F. Appelbaum, 2021, Leukemia.

Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning

M. Horowitz, D. Weisdorf, M. Arora, 2011 .

Impaired responsiveness to B cell growth factor in a patient with common variable hypogammaglobulinemia

D. Weisdorf, R. Perri, 1985 .

Time-to-Event Ratio to Predict Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation?

Jeffrey S. Miller, S. Devine, D. Weisdorf, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation.

W. Woods, B. Bostrom, D. Weisdorf, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report

S. Bhatia, D. Weisdorf, M. Arora, 2021, Blood advances.

Loss of microbiota-derived protective metabolites after neutropenic fever

A. Khoruts, C. Staley, S. Ramamoorthy, 2022, Scientific Reports.

An alpha‐defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft‐versus‐host disease

R. Jenq, C. Staley, D. Weisdorf, 2020, British journal of haematology.

Human Herpesvirus-6 Reactivation and Acute Graft-versus-Host Disease.

D. Weisdorf, A. Rashidi, M. Ebadi, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

RECURRENT VENOUS THROMBOSIS ASSOCIATED WITH INHERITED DEFICIENCY OF HEPARIN COFACTOR II

D. Weisdorf, J. R. Edson, 1991, British journal of haematology.

Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

Stephanie J. Lee, G. Hill, P. Ordentlich, 2020 .

Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.

D. Weisdorf, V. Bachanova, J. Lamba, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impaired responsiveness to B cell growth factor in a patient with common variable hypogammaglobulinemia.

D. Weisdorf, R. T. Perri, 1985, Blood.

A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, Leukemia & lymphoma.

A modified comorbidity index for hematopoietic cell transplantation

C. Le, D. Weisdorf, M. Arora, 2010, Bone Marrow Transplantation.

Mucositis and alpha-streptococcal sepsis in bone marrow transplant recipients.

B. Bostrom, D. Weisdorf, 1984, Lancet.

Rash and GI symptoms on day +36.

D. Weisdorf, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia

A. Khoruts, C. Staley, S. Ramamoorthy, 2021, Blood advances.

Allogeneic and autologous bone marrow transplantation for acute lymphoblastic leukemia.

W. Woods, T. Lebien, F. Uckun, 1990, Haematology and blood transfusion.

Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.

P. Flynn, G. Vercellotti, D. Weisdorf, 1984, Inflammation.

Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2019, Leukemia.

Novel disease burden assessment predicts allogeneic transplantation outcomes in myelodysplastic syndrome

D. Weisdorf, T. DeFor, Z. Sachs, 2016, Bone Marrow Transplantation.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation

Robin R. Shields-Cutler, D. Knights, D. Weisdorf, 2019, PloS one.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402

D. Weisdorf, B. Blazar, M. Verneris, 2017, Bone Marrow Transplantation.

Comparison of Outcomes for Non-Myeloablative (NMA) and Myeloablative (MA) Conditioning for Adults with Acute Lymphoblastic Leukaemia (ALL) in First and Second Complete Remission (CR): a Center for International Blood and Marrow Transplant Research (CIBMTR) Analyisis.

J. Dipersio, M. Tallman, Tao Wang, 2009 .

Auer rod positive dysmyelopoietic syndrome

M. Oken, D. Weisdorf, R. Rydell, 1981, American journal of hematology.

Inpatient Healthcare Resource Utilization, Costs, and Mortality in Adult Patients With Acute Graft-Versus-Host Disease, Including Steroid-Refractory or High-Risk Disease, Following Allogeneic Hematopoietic Cell Transplantation.

D. Weisdorf, S. Parasuraman, Jingbo Yu, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors

J. Wagner, D. Weisdorf, N. Majhail, 2011 .

Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis

Robin R. Shields-Cutler, D. Knights, A. Khoruts, 2020, British journal of haematology.

Pre-transplant recovery of microbiome diversity without recovery of the original microbiome

A. Khoruts, C. Staley, D. Weisdorf, 2018, Bone Marrow Transplantation.

The Importance of Surveillance Stool Cultures During Periods of Severe Neutropenia

D. Weisdorf, F. Rhame, P. Ferrieri, 1987, Infection Control.

Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.

K. Dusenbery, R. Gawande, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

K. Rezvani, D. Marin, E. Shpall, 2023, Blood advances.

Which donor or graft source should you choose for the strongest GVL? Is there really any difference.

D. Weisdorf, 2013, Best practice & research. Clinical haematology.

A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802

P. Westervelt, M. Pasquini, M. Horowitz, 2013 .

The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.

D. Weisdorf, A. Bracey, C. Anasetti, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ruxolitinib Plus Nivolumab in Patients with R/R Hodgkin Lymphoma after Failure of Check-Point Inhibitors: Preliminary Report on Safety and Efficacy

J. Zak, D. Weisdorf, U. Farooq, 2021, Blood.

Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantation

S. Bhatia, D. Weisdorf, M. Arora, 2019, Cancer.

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

K. Owzar, C. Hofmeister, P. Richardson, 2009 .

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

W. Wood, Bryce Waldman, Z. DeFilipp, 2023, Blood reviews.

Economic Challenges in Hematopoietic Cell Transplantation: How Will New and Established Programs Face the Growing Costs?

J. Szer, D. Weisdorf, A. Srivastava, 2017, Biology of Blood and Marrow Transplantation.

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease.

M. MacMillan, D. Weisdorf, B. Blazar, 2023, Transplantation and cellular therapy.

BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD)

M. Horowitz, J. Wingard, D. Weisdorf, 2008 .

Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

D. Weisdorf, J. Cornelissen, S. Holtan, 2021, Journal of Clinical Oncology.

Recombinant Human IL-15 Promotes in Vivo Expansion of Adoptively Transferred NK Cells in a First-in-Human Phase I Dose Escalation Study in Patients with AML

T. Waldmann, Jeffrey S. Miller, D. Weisdorf, 2012 .

Bone marrow transplantation for acute leukemia.

D. Weisdorf, 1987, Investigative radiology.

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

D. Neuberg, S. Sallan, B. Sandmaier, 2014 .

Multiple transmissions of chromosomally integrated human herpesvirus‐6 in one family

D. Weisdorf, A. Rashidi, E. Warlick, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML

A. Khoruts, David Kazadi, D. Weisdorf, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial.

D. Weisdorf, B. Blazar, J. Kersey, 1997, American journal of hematology.

Haploidentical Natural Killer (NK) Cells Expanding In Vivo After Adoptive Transfer Exhibit Hyperfunction That Partially Overcomes Self Tolerance and Leads to Clearance of Refractory Leukemia

K. Dusenbery, Jeffrey S. Miller, D. Weisdorf, 2011 .

High risk of relapse with intermediate dose cytarabine for consolidation in young favourable‐risk acute myeloid leukaemia patients following induction with 7+3: a retrospective multicentre analysis and critical review of the literature

D. Weisdorf, Z. Sachs, Q. Cao, 2021, British journal of haematology.

Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients

S. Bhatia, D. Weisdorf, Yanjun Chen, 2023, JACC: CardioOncology.

Venous thromboembolism in Autologous Blood or Marrow Transplant Survivors: A report from Blood or Marrow Transplant Survivor Study.

S. Bhatia, D. Weisdorf, M. Arora, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single or Multiple HLA-A, B, C or DRB1 Mismatches Limit Success of Unrelated Donor Bone Marrow Transplantation.

J. Klein, M. Horowitz, Stephanie J. Lee, 2006 .

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).

J. Wagner, Priya Kumar, Jeffrey S. Miller, 2005 .

Allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemia.

F. Uckun, B. Jansen, D. Weisdorf, 1992, Leukemia.

Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report

D. Weisdorf, M. Arora, S. Forman, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].

P. Hari, M. Pasquini, M. Horowitz, 2021, Transplantation and Cellular Therapy.

Healthcare Resource Utilization (HCRU) and Costs Associated with Acute Graft-vs-Host Disease (aGVHD) Following Allogeneic Hematopoietic Stem Cell Transplant (a-HSCT): A Retrospective Claims Database Analysis

D. Weisdorf, S. Parasuraman, Jingbo Yu, 2018 .

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2009 .

Umbilical Cord Blood Transplant after Reduced Intensity Conditioning Provides Outcomes Comparable HLA-Matched Siblings for Patients with High Risk and Advanced Acute Myeloid Leukemia.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2006 .

Diffuse alveolar hemorrhage (DAH) and infection associated alveolar hemorrhage (IAH) following hematopoietic stem-cell transplantation: Related and high risk clinical syndromes with poor response to high-dose corticosteroids

D. Weisdorf, N. Majhail, K. Parks, 2006 .

Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy

I. Lewis, D. Weisdorf, D. Weisdorf, 2000, Bone Marrow Transplantation.

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

J. L. Goodman, W. Powderly, T. Shea, 1992, The New England journal of medicine.

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

J. Tolar, Jeffrey S. Miller, S. Spellman, 2016 .

Bone marrow transplantation for acute lymphocytic leukemia (ALL).

D. Weisdorf, 1997, Leukemia.

Origins of circulating endothelial cells and endothelial outgrowth from blood.

R. Hebbel, D. Weisdorf, A. Solovey, 2000, The Journal of clinical investigation.

A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.

G. Schoch, D. Weisdorf, S. Slichter, 1995, Blood.

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

M. Reding, D. Weisdorf, M. Reding, 2015, Bone Marrow Transplantation.

Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

C. Ebens, G. Vercellotti, Jeffrey S. Miller, 2023, Transplantation and cellular therapy.

Severe/Life-Threatening/Fatal Chronic Health Conditions (CHCs) after Allogeneic Blood or Marrow Transplantation (BMT) in Childhood - a Report from the BMT Survivor Study (BMTSS)

S. Bhatia, D. Weisdorf, M. Arora, 2020 .

Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2015 .

Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia

Jeffrey S. Miller, J. Gotlib, D. Weisdorf, 2017, American journal of hematology.

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.

P. Hari, M. Mohty, M. Aljurf, 2020, Hematology/oncology and stem cell therapy.

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission.

E. Thiel, A. Rimm, M. Horowitz, 1991, Annals of internal medicine.

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.

S Mackinnon, S. Mackinnon, T. Spitzer, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic

J. Sierra, J. Dipersio, S. Tarima, 2011 .

Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy

A. Khoruts, C. Staley, D. Weisdorf, 2019, PloS one.

Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia

Robin R. Shields-Cutler, A. Khoruts, C. Staley, 2019, Scientific Reports.

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

D. Weisdorf, N. Ramsay, D. Weisdorf, 1998, Bone Marrow Transplantation.

Occult intracellular calcium pools: relevance to neutrophil oxidant production.

D. Weisdorf, M. Thayer, 1989, The Journal of laboratory and clinical medicine.

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.

A. Nademanee, A. Begovich, C. Kollman, 2001, Blood.

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.

S. Davies, D. Weisdorf, B. Blazar, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First-in-Human Phase I Study of Nicotinamide-Expanded Related Donor Natural Killer Cells for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Jeffrey S. Miller, D. Weisdorf, V. Bachanova, 2019, Biology of Blood and Marrow Transplantation.

Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation

D. Weisdorf, D. Fair, D. Hasegawa, 1989, British Journal of Haematology.

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission

M. Tanimoto, M. Tomonaga, R. Ohno, 1998, Bone Marrow Transplantation.

Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study

M. Pasquini, U. Popat, V. Bhatt, 2019, Blood.

THE IMMUNOPATHOLOGY OF UPPER GASTROINTESTINAL ACUTE GRAFT‐VERSUS-HOST DISEASE LYMPHOID CELLS AND ENDOTHELIAL ADHESION MOLECULES

J. Platt, D. Weisdorf, J. Roy, 1993, Transplantation.

Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.

Bin Zhang, Jeffrey S. Miller, D. Weisdorf, 2014, Blood.

M. Pasquini, M. Horowitz, J. Wingard, 2009, Blood.

HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.

A. Nademanee, M. Horowitz, S. Spellman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

C. Le, P. Parham, Jeffrey S. Miller, 2010, Blood.

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Jeffrey S. Miller, D. Weisdorf, B. Blazar, 2008 .

cells is improved using IL-2 diphtheria toxin fusion protein Clearance of acute myeloid leukemia by haploidentical natural killer

Bin Zhang, D. Weisdorf, B. Blazar, 2014 .

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 × 33 Bispecific Killer Cell Engager and ADAM17 Inhibition

Bin Zhang, Jeffrey S. Miller, J. Ross, 2013, Clinical Cancer Research.

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Jeffrey S. Miller, D. Weisdorf, M. Verneris, 2011, Blood.

Pre‐transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft‐versus‐host disease

Benjamin M Hillmann, Robin R. Shields-Cutler, A. Khoruts, 2023, British journal of haematology.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

B. Storer, J. Pidala, Stephanie J. Lee, 2011, Blood.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

Radiologic and nuclear events: contingency planning for hematologists/oncologists.

R. Hatchett, D. Weinstock, D. Weisdorf, 2008, Blood.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

J. Wagner, K. Dusenbery, M. MacMillan, 2015, Blood.

An alpha‐defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft‐versus‐host disease

R. Jenq, C. Staley, D. Weisdorf, 2020, British journal of haematology.

Impact of Cytogenetics on Outcome of Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Adults with AML.

J. Mehta, M. Tallman, G. Dewald, 2004 .

Aggressive combined modality treatment of progressive sinonasal fungal infections in immunocompromised patients.

D. Weisdorf, N. Berlinger, D. Weisdorf, 1988, The American journal of medicine.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.

R. Vij, M. Perales, F. Appelbaum, 2015, Blood.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Survival after T-Cell Replete Haplo-Identical Related Donor Transplant Using Post-Transplant Cyclophosphamide Compared with Matched Unrelated Donor Transplant for Acute Myeloid Leukemia

R. Vij, M. Perales, F. Appelbaum, 2014 .

Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.

K. Dusenbery, R. Gawande, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association Between Genetic Variants in the Base Excision Repair Pathway and Outcomes After Hematopoietic Cell Transplant.

B. Lindgren, M. Gross, S. Basu, 2009 .

Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome.

D. Weisdorf, V. Bachanova, L. Burns, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation.

D. Weisdorf, A. Blaes, Jo-Anne H. Young, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

M. Horowitz, R. Gale, Stephanie J. Lee, 2010 .

Second-Generation Camelid Trike Induces Improved NK Cell Mediated Targeting of AML in Pre-Clinical Models

Jeffrey S. Miller, D. Weisdorf, M. Geller, 2017 .

Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

S. Bhatia, D. Weisdorf, S. Forman, 2011, Blood.

N. Geller, A. Krishnan, P. Hari, 2011, The Lancet. Oncology.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

M. MacMillan, D. Weisdorf, T. Defor, 2012, British Journal of Haematology.

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.

D. Weisdorf, M. Arora, M. Eapen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

J. Bolaños-Meade, Juan Wu, D. Weisdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stroke Risk in Blood or Marrow Transplant (BMT) Survivors - a Report from the BMT Survivor Study (BMTSS)

S. Bhatia, D. Weisdorf, M. Arora, 2019, Blood.

Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation.

W. Guan, K. Hsu, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

J. Weiss, Stephanie J. Lee, O. Schueller, 2018, Blood.

A Phase I Study of Intravenous NCI IL-15 to Enhance Adoptively Transferred NK Cells Uncovers Defects in CD16 Triggered IFNγ Production and Competition Between Donor NK and Recipient T Cells

T. Waldmann, Jeffrey S. Miller, D. Weisdorf, 2015 .

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

W. Wood, J. Pidala, Yi-Bin Chen, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Burdern of Long-Term Morbidity after Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor Study (BMTSS).

L. Robison, T. Kawashima, S. Bhatia, 2007 .

Impact of Long-Term Sequelae Diagnosed after Hematopoietic Cell Transplantation (HCT) on Health-Related Quality of Life (HRQL): A Report from the Bone Marrow Transplant Survivor Study.

S. Bhatia, D. Weisdorf, S. Forman, 2006 .

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

L. Weiner, Jeffrey S. Miller, J. Ross, 2014, Blood.